CompaniesHorizon Therapeutics

Horizon Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

1

As Collaborator

2

Total Enrollment

119

By Phase

PHASE4: 1PHASE1: 1EARLY_PHASE1: 1

By Status

NOT_YET_RECRUITING: 1COMPLETED: 1ACTIVE_NOT_RECRUITING: 1

Recent Trials

NCT06212245Collaborator
A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders
PHASE4Not yet recruiting
33 participants
Started: Feb 25, 2024 · Completed: Jun 25, 2025
NCT05565768Lead Sponsor
Study to Evaluate HZN-457 in Healthy Volunteers
PHASE1Completed
36 participants
Started: Nov 22, 2022 · Completed: Aug 9, 2023
NCT04937062Collaborator
Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy
EARLY_PHASE1Active, not recruiting
50 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2025
Funding History (3)
D
Mar 17, 2010
Filing
D/A
Mar 16, 2010
Filing
D/A
Jul 22, 2009
Filing
Related Companies
Amgen
acquired